Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Neurology therapeutics Market Research Reports

Titlepublishedprice

Migraine - Pipeline Review, H2 2016

By Global Markets Direct
"...... he causes throbbing or pulsating pain, usually on only one side of the head. These headaches are often associated with nausea, vomiting, and extreme sensitivity to light and sound. Symptoms include problems speaking, tingling in face, arms, and shoul......"
23-Nov-2016$2000

Diabetic Neuropathy - Pipeline Review, H2 2016

By Global Markets Direct
"...... rves that allow feeling things such as pain. Symptoms include tingling, numbness, burning and pain. The predisposing factors are obesity, hypertension, high lipid and sugar levels, smoking, etc. It may be managed by medication and dietary modificatio......"
16-Nov-2016$2000

Vascular Dementias-Pipeline Insights, 2016

By Delve Insight
"...... cal, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designa......"
01-Nov-2016$1250

Myasthenia Gravis-Pipeline Insights, 2016

By Delve Insight
"...... l, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designati......"
01-Nov-2016$1250

Narcolepsy-Pipeline Insights, 2016

By Delve Insight
"...... I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. D......"
01-Nov-2016$1250

Dyskinesia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... derstand the market and pipeline status of the drugs around the Dyskinesia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provide......"
01-Nov-2016$2000

Down Syndrome-Pipeline Insights, 2016

By Delve Insight
"...... Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations deta......"
01-Nov-2016$1250

Drug Addiction-Pipeline Insights, 2016

By Delve Insight
"...... , Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations de......"
01-Nov-2016$1250

Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... t is to understand the market and pipeline status of the drugs around the Absence Seizure to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's......"
01-Nov-2016$2000

Dystonia-Pipeline Insights, 2016

By Delve Insight
"...... hase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Delve......"
01-Nov-2016$1250

Avail upto 50% Discount on below Publisher Reports.